Reducing dietary BCAAs rapidly reverses diet-induced obesity and improves glycemic control in obese mice, suggesting that reducing dietary BCAAs may be helpful in the treatment of obese and insulin-resistant patients. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.